Adicet Bio, Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Adicet Bio, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2020-09-30 was $114.08M.
- Adicet Bio, Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2018-03-31 was $81.62M.
- Adicet Bio, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $114.08M.
- Adicet Bio, Inc. stock issued during period, value, conversion of convertible securities for fiscal 2018 was $81.62M.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2020-12-31 | $114.08M 10-K · filed 2022-03-15 | |
| 2020-09-30 | $114.08M 10-Q · filed 2021-11-10 | |
| 2018-12-31 | $81.62M 10-K · filed 2020-03-12 | |
| 2018-03-31 | $81.62M 10-Q · filed 2019-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |